Two Penguins Investment
Preparing your financial briefing…
Financial Intelligence
Recent perspective
Recent financial reporting selected by recency, stored importance, and source diversity.
Live chronology
Page 547 · Newest reporting first
Channel NewsAsia Businesscommoditiesinvestment opinion
Chevron's involvement may serve as a proof of concept for attracting capital to a potential Venezuelan oil expansion. The commentary highlights the gap between political rhetoric and practical investment conditions.
Nasdaq Marketsmarketsmarket event
Lululemon's stock fell sharply as fashion trends shift away from its core offerings. The move reflects investor concern about weakening demand for the brand.
Nasdaq Marketsmarketsmarket event
Dogecoin declined after a stronger-than-expected August jobs report raised the odds of a September rate hike. The labor market data shifted expectations for monetary policy.
Nasdaq Markets
Tesla held a launch event for its Cybercab in Austin, but the product is now reportedly facing a federal probe within 24 hours. The situation marks a rapid shift from promotion to regulatory scrutiny.
Nasdaq Marketscompaniescorporate event
Lululemon shares closed down 17.38% after the company cut its full-year revenue and earnings outlook again. Investors are watching how effectively the new CEO can turn performance around.
Nasdaq Marketscompaniesearnings
Planet Labs shares slipped 1.28% despite an earnings beat and full-year guidance raise. Mixed premarket analyst updates contributed to the muted reaction.
Nasdaq Marketsmarketsinvestment opinion
Appaloosa cut its Micron position by 41% during the second quarter, selling 690,000 shares. Micron remains the fund's second-biggest holding.
Nasdaq Marketstechnologycorporate event
HP announced new OmniBook Ultra 16 and OmniBook X 14 PCs, along with details of the upcoming OmniDesk. The devices are powered by NVIDIA RTX Spark and Windows.
Nasdaq Marketscompaniescorporate event
Stanley Black & Decker announced a definitive agreement to sell its Excel Industries business to Bad Boy Mowers.
Nasdaq Marketsregulationregulatory action
Lupin received U.S. FDA approval for its Abbreviated New Drug Application for Modafinil Tablets USP, 100 mg and 200 mg.